Sign In
Buy PRQR
$1.72
-0.0600 (-3.37%)
At Close: Jul 31, 2026
ProQR Announces Highlights from Analyst Event
09:01pm, Thursday, 18'th Nov 2021 GlobeNewswire Inc.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tr
ProQR Announces Highlights from Analyst Event
09:01pm, Thursday, 18'th Nov 2021 Intrado Digital Media
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the Company), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today hosted a virtual Analyst Event. Management provided an in-depth review of the Companys clinical-stage programs and RNA editing technology platforms.
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
12:52pm, Thursday, 18'th Nov 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Roche's Spark Subsidiary Reports Positive Phase 1/2 Data For Hemophilia Gene Therapy Candidate
Roche H
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
02:57pm, Sunday, 14'th Nov 2021 Benzinga
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Among the
ProQR Announces Upcoming Investor Conferences in November and December
04:30pm, Monday, 08'th Nov 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
ProQR Appoints Theresa Heggie as Chief Commercial Officer
08:00am, Monday, 04'th Oct 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the creation of transformative R
Investment Case On ProQR Therapeutics Gets More Enticing
03:06pm, Friday, 01'st Oct 2021
Today, we revisit ProQR Therapeutics, an intriguing developmental concern for the first time since early this year.
Implied Volatility Surging for ProQR (PRQR) Stock Options
11:11am, Monday, 13'th Sep 2021
Investors need to pay close attention to ProQR (PRQR) stock based on the movements in the options market lately.
Here's Why ProQR Stock Surged on Thursday
04:42pm, Thursday, 09'th Sep 2021
A new collaboration deal with Eli Lilly could be worth up to $1.3 billion.
PRQR Stock: Why It Is Trading Higher Today
11:00am, Thursday, 09'th Sep 2021
The stock price of ProQR Therapeutics N.V. (Nasdaq: PRQR) increased over 13% pre-market this morning.
ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform
04:15pm, Wednesday, 08'th Sep 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the creation of transformative
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
04:01pm, Wednesday, 08'th Sep 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), today announced a global licensing and research collaboration with Eli Lill
ProQR Announces Virtual Presentation at EURETINA 2021
04:15pm, Monday, 06'th Sep 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 06, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ther
ProQR Announces Upcoming Investor Conferences
08:00am, Friday, 03'rd Sep 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference
04:30pm, Wednesday, 11'th Aug 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tran
